2015-004121-13
A Multicenter Open-label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Investigate Efficacy, Safety and Pharmacokinetics after Dose Escalation in Japanese Subjects with Crohn's Disease
AbbVie GK·EU Clinical Trials Register
Study focus
- Disease/Condition
- Crohn's Disease
Sponsor & location
- Primary sponsor
- AbbVie GK
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Subject with suspicion of colitis other than Crohn's disease.
ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease [regional enteritis]Crohn disease of small intestine
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2015-004121-13
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2015-004121-13 through Pure Global AI's free database. This phase not specified trial is sponsored by AbbVie GK and is currently status unknown. The study focuses on Crohn's Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.